版本:
中国

BRIEF-CTI Biopharma announces license and agreement expansion with Servier to commercialize Pixuvri

April 25 Cti Biopharma Corp:

* Servier and CTI biopharma expand license and collaboration agreement to develop and commercialize Pixuvri

* Servier will commercialize Pixuvri in all markets except the US

* Will retain rights to commercialize Pixuvri in the US

* Servier will pay Co 12 million euros ($13.0 million) with potential for Co to receive eur 76 million in additional sales and regulatory milestone payments as well as royalties on net product sales Source text for Eikon: Further company coverage: ($1 = 0.9201 euros) (Gdynia Newsroom)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐